Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

Clinical trial NCT00089362 · COMPLETED

Trial details

NCT number: NCT00089362
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Male Breast Cancer Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Recurrent Basal Cell Carcinoma of the Lip Recurrent Breast Cancer Recurrent Colon Cancer Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity Recurrent Gastric Cancer Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity Recurrent Lymphoepithelioma of the Nasopharynx Recurrent Lymphoepithelioma of the Oropharynx Recurrent Melanoma Recurrent Metastatic Squamous Neck Cancer With Occult Primary

Start date: 2004-07-01
Primary completion: 2008-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.